JASON KRUSE: Open Payments
NPI 1295815330 · KINSLEY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,704 in 113 payments from 17 companies in 2025. Trend: 2023 $2,503 · 2024 $2,630 · 2025 $2,704
Food & beverage: $2,649Education: $55
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $623 |
| ABBVIE INC. | 17 | $357 |
| Janssen Biotech, Inc. | 14 | $313 |
| GENZYME CORPORATION | 7 | $309 |
| E.R. Squibb & Sons, L.L.C. | 22 | $239 |
| Lilly USA, LLC | 5 | $170 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $168 |
| Amgen Inc. | 8 | $167 |
| PFIZER INC. | 6 | $137 |
| Kerecis Limited | 3 | $51 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, COSENTYX, Sotyktu, OTEZLA, Rhapsido, EBGLYSS.
Industry payments across KS — which companies pay providers there.
